Adial Pharmaceuticals earnings were -$13.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ADIL earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.1M, down 5.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADIL reported annual earnings of -$13.2M, with 157.6% growth. The next ADIL earnings date is May 12, 2025.
Adial Pharmaceuticals Earnings Reports & History FAQ
What were Adial Pharmaceuticals's earnings last quarter?
On ADIL's earnings call on Invalid Date, Adial Pharmaceuticals (NASDAQ: ADIL) reported Q4 2024 earnings per share (EPS) of -$0.15, up 79.73% year over year. Total ADIL earnings for the quarter were -$2.07 million. In the same quarter last year, Adial Pharmaceuticals's earnings per share (EPS) was -$0.74.
The next ADIL earnings call is Invalid Date. Add ADIL to your watchlist to be reminded of Adial Pharmaceuticals's next earnings date.
What was ADIL's earnings growth in the past year?
As of Adial Pharmaceuticals's earnings date in Invalid Date, Adial Pharmaceuticals's earnings has grown year over year. ADIL earnings in the past year totalled -$13.20 million.
Is Adial Pharmaceuticals profitable or losing money?
As of the last Adial Pharmaceuticals earnings report, Adial Pharmaceuticals is currently losing money. Adial Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$13.20 million, a 157.59% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.